Literature DB >> 2403178

Risk factors associated with the increasing prevalence of pneumonia during pregnancy.

K Berkowitz1, A LaSala.   

Abstract

A retrospective chart review of 1120 antepartum admissions revealed the prevalence of antepartum pneumonia rose to 1 per 367 deliveries. A total of 26 cases in 9560 deliveries were identified with criteria of fever greater than 39 degrees C, productive cough, and radiologic findings of infiltrates or consolidation. Pregnancy-related outcome variables studied were prevalence of preterm labor or birth, birth weight, and trimester of occurrence. Pneumonia characteristics studied were rate and type of organisms recovered, seasonality, and severity of the illness and radiologic findings. Exposure variables relating to the development of pneumonia studied were underlying medical conditions, hematocrit, human immunodeficiency virus status, and drug use. Birth weight, hematocrit, human immunodeficiency virus status, and drug use were compared with a randomly selected sample of women drawn from the general population delivered of infants during the study time period. One patient experienced preterm delivery, which occurred 1 month after cure of pneumonia. Birth weight was significantly lower in the study group (2770 +/- 224 gm versus 3173 +/- 99 gm, p less than 0.01). The most common organism recovered was Streptococcus pneumoniae. A total of 42% of patients had multilobar involvement and two required intubation. Cocaine use (52% in the study group versus 10% in the general population, p less than 0.01) and human immunodeficiency virus positivity (24% in the study group versus 2% in the general population, p less than 0.01) were significant risk factors for antepartum pneumonia.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2403178     DOI: 10.1016/0002-9378(90)91109-p

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  31 in total

Review 1.  Pneumonia and pregnancy.

Authors:  W S Lim; J T Macfarlane; C L Colthorpe
Journal:  Thorax       Date:  2001-05       Impact factor: 9.139

2.  Pregnancy preserves pulmonary function following influenza virus infection in C57BL/6 mice.

Authors:  Meghan S Vermillion; Andrew Nelson; Landon Vom Steeg; Jeffery Loube; Wayne Mitzner; Sabra L Klein
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-05-31       Impact factor: 5.464

Review 3.  Vertical transmission of SARS-CoV-2: A systematic review.

Authors:  Kristine Jeganathan; Anthea Bm Paul
Journal:  Obstet Med       Date:  2022-06

4.  Varicella during pregnancy. Maternal and fetal effects.

Authors:  V L Katz; J A Kuller; M J McMahon; M A Warren; S R Wells
Journal:  West J Med       Date:  1995-11

5.  The reporting of HIV/AIDS deaths in women.

Authors:  J W Buehler; D L Hanson; S Y Chu
Journal:  Am J Public Health       Date:  1992-11       Impact factor: 9.308

Review 6.  Acute respiratory failure in pregnancy.

Authors:  Stephen E Lapinsky
Journal:  Obstet Med       Date:  2015-06-10

7.  [Infection by SARS-CoV-2 in pregnancy and possibility of transmission to neonates: A systematic revision].

Authors:  M J Cabero-Pérez; I Gómez-Acebo; T Dierssen-Sotos; J Llorca
Journal:  Semergen       Date:  2020-06-23

Review 8.  The management of respiratory infections during pregnancy.

Authors:  Vanessa Laibl; Jeanne Sheffield
Journal:  Immunol Allergy Clin North Am       Date:  2006-02       Impact factor: 3.479

9.  SARS-CoV-2 Infection in Pregnancy - a Review of the Current Literature and Possible Impact on Maternal and Neonatal Outcome.

Authors:  Florian M Stumpfe; Adriana Titzmann; Michael O Schneider; Patrick Stelzl; Sven Kehl; Peter A Fasching; Matthias W Beckmann; Armin Ensser
Journal:  Geburtshilfe Frauenheilkd       Date:  2020-03-26       Impact factor: 2.915

10.  The association between periodontal disease and adverse pregnancy outcomes in Northern Tanzania: a cross-sectional study.

Authors:  Nyobasi Gesase; Jaume Miranda-Rius; Lluís Brunet-Llobet; Eduard Lahor-Soler; Michael J Mahande; Gileard Masenga
Journal:  Afr Health Sci       Date:  2018-09       Impact factor: 0.927

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.